Urgent Recall: Incorrect Labelling Found in Accord Healthcare’s Ipratropium Bromide Nebuliser Solution
An urgent recall has been issued for Ipratropium Bromide 500 microgram/2ml Nebuliser Solution by Accord Healthcare Ltd due to incorrect […]
An urgent recall has been issued for Ipratropium Bromide 500 microgram/2ml Nebuliser Solution by Accord Healthcare Ltd due to incorrect […]
On October 23, 2025, ongoing developments in epilepsy treatment reached a new milestone with an update from the trial sponsored
Stanford University is spearheading a new clinical trial titled Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With
The upcoming clinical trial for the innovative CaRi-Heart® Analysis is set to redefine risk assessment in coronary artery disease, atherosclerosis,
Cosmo Artificial Intelligence-AI Ltd has announced a novel clinical trial aiming to explore the integration of GI Genius™ XR software
Yale University, in collaboration with MQ: Transforming Mental Health, announced a new clinical trial exploring the effectiveness of parent-based interventions
Clinical trials are advancing the intersection of gut microbiota research and medical devices with new studies evaluating plant-based and meat-based
Swissmedic has announced the first authorization for Sogroya®, marking a significant regulatory development. The approval introduces a new option within
Bradley Hospital has initiated a groundbreaking clinical trial exploring accelerated intermittent theta burst stimulation (iTBS) as a tool to improve
A clinical trial investigating the innovative 2-D Monochromatic X-ray Mammography System has been listed on ClinicalTrials.gov, marking an important step